Clinical impact of the detector size effect in 3D-CRT.
The detector size artificially increases the measured penumbra of radiotherapy fields. The aim of this work is to determine the influence of the detector size when planning three-dimensional conformal radiation therapy (3D-CRT) treatments. Two anatomical sites of interest in 3D-CRT were studied: prostate and hypophysis chordoma. Conventional 3D-CRT treatments for two cases in these locations were planned with a FOCUS 4.0.0 (Computerized Medical Systems, USA) treatment planning system (TPS) equipped with Fast Fourier Transform Convolution (FFTC) and Multigrid Superposition (MGS) algorithms, making use of beams modelled from radiation profiles measured either with a 2.0 mm diameter detector (PFD(3G) diode) or with a 5.5 mm diameter detector (PTW-31002 ionisation chamber). These detectors cover up the range of detector sizes commonly used to measure radiation profiles for 3D-CRT. Dose-volume histograms (DVHs), radiobiological indexes, tumor control probability (TCP) and normal tissue complication probability (NTCP) were analysed and compared for planning target volumes (PTVs) and organs at risk (OAR) studied. Important differences in DVH were found. OAR received higher dose levels when a 5.5 mm detector was used to measure profiles compared to the case in which a 2.0 mm detector was used. A 2 Gy increment in the mean rectal dose was found when the larger detector was used. In the same way, NTCP of brain stem in hypophysis chordoma treatments was doubled when this detector was used. The current use of ionisation chambers of about 5 mm active diameter to get the necessary data to model treatment machines in radiotherapy treatment planning systems (TPS) implies a significant overirradiation of OAR close to the PTV in 3D-CRT treatments due to errors in the measured penumbra of beam profiles. To avoid this overirradiation, the measured profiles should either being acquired with a suitable detector size (2-3 mm active diameter) or being deconvoluted.